1.
|
1. | | 2. | | 3. | | 4. | Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC.Jing W, Xu T, Wu L, Lopez PB, Grassberger C, Ellsworth SG, Mohan R, Hobbs BP, Blumenschein GR, Tu J, Altan M, Lee P, Liao Z, Lin SH. JTO Clin Res Rep. 2022 Aug 7;3(9):100391. doi: 10.1016/j.jtocrr.2022.100391. eCollection 2022 Sep. PMID: 36089921 Free PMC article. | 5. | | 6. | | 7. | | 8. | | 9. | | 10. | | 11. | A computational approach to quantifying miscounting of radiation-induced double-strand break immunofluorescent foci.Ingram SP, Warmenhoven JW, Henthorn NT, Chadiwck AL, Santina EE, McMahon SJ, Schuemann J, Kirkby NF, Mackay RI, Kirkby KJ, Merchant MJ. Commun Biol. 2022 Jul 14;5(1):700. doi: 10.1038/s42003-022-03585-5. PMID: 35835982 Free PMC article. | 12. | | 13. | Impact of DNA Geometry and Scoring on Monte Carlo Track-Structure Simulations of Initial Radiation-Induced Damage.Bertolet A, Ramos-Méndez J, McNamara A, Yoo D, Ingram S, Henthorn N, Warmenhoven JW, Faddegon B, Merchant M, McMahon SJ, Paganetti H, Schuemann J. Radiat Res. 2022 Sep 1;198(3):207-220. doi: 10.1667/RADE-21-00179.1. PMID: 35767729 | 14. | | 15. | Consistency checks of results from a Monte Carlo code intercomparison for emitted electron spectra and energy deposition around a single gold nanoparticle irradiated by X-rays.Rabus H, Li WB, Nettelbeck H, Schuemann J, Villagrasa C, Beuve M, Di Maria S, Heide B, Klapproth AP, Poignant F, Qiu R, Rudek B. Radiat Meas. 2021 Sep;147:106637. doi: 10.1016/j.radmeas.2021.106637. Epub 2021 Jul 30. PMID: 35669292 Free PMC article. | 16. | | 17. | | 18. | Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy.Chamseddine I, Kim Y, De B, El Naqa I, Duda DG, Wolfgang J, Pursley J, Paganetti H, Wo J, Hong T, Koay EJ, Grassberger C. JCO Clin Cancer Inform. 2022 Feb;6:e2100169. doi: 10.1200/CCI.21.00169. PMID: 35192402 | 19. | | 20. | | 21. | | 22. | | 23. | Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy.Cho Y, Kim Y, Chamseddine I, Lee WH, Kim HR, Lee IJ, Hong MH, Cho BC, Lee CG, Cho S, Kim JS, Yoon HI, Grassberger C. Radiother Oncol. 2022 Mar;168:1-7. doi: 10.1016/j.radonc.2022.01.007. Epub 2022 Jan 13. PMID: 35033601 | 24. | | 25. | | 26. | DNA damage modeled with Geant4-DNA: effects of plasmid DNA conformation and experimental conditions.D-Kondo N, Moreno-Barbosa E, Štěphán V, Stefanová K, Perrot Y, Villagrasa C, Incerti S, De Celis Alonso B, Schuemann J, Faddegon B, Ramos-Méndez J. Phys Med Biol. 2021 Dec 15;66(24). doi: 10.1088/1361-6560/ac3a22. PMID: 34787099 | 27. | | 28. | Application of High-Z Gold Nanoparticles in Targeted Cancer Radiotherapy-Pharmacokinetic Modeling, Monte Carlo Simulation and Radiobiological Effect Modeling.Li WB, Stangl S, Klapproth A, Shevtsov M, Hernandez A, Kimm MA, Schuemann J, Qiu R, Michalke B, Bernal MA, Li J, Hürkamp K, Zhang Y, Multhoff G. Cancers (Basel). 2021 Oct 26;13(21):5370. doi: 10.3390/cancers13215370. PMID: 34771534 Free PMC article. | 29. | | 30. | Adaptive proton therapy.Paganetti H, Botas P, Sharp GC, Winey B. Phys Med Biol. 2021 Nov 15;66(22):10.1088/1361-6560/ac344f. doi: 10.1088/1361-6560/ac344f. PMID: 34710858 Free PMC article. Review. | 31. | Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma.Waldschmidt JM, Kloeber JA, Anand P, Frede J, Kokkalis A, Dimitrova V, Potdar S, Nair MS, Vijaykumar T, Im NG, Guillaumet-Adkins A, Chopra N, Stuart H, Budano L, Sotudeh N, Guo G, Grassberger C, Yee AJ, Laubach JP, Richardson PG, Anderson KC, Raje NS, Knoechel B, Lohr JG. Clin Cancer Res. 2021 Dec 1;27(23):6432-6444. doi: 10.1158/1078-0432.CCR-21-2040. Epub 2021 Sep 13. PMID: 34518309 Free PMC article. | 32. | | 33. | TOPAS-nBio validation for simulating water radiolysis and DNA damage under low-LET irradiation.Ramos-Méndez J, LaVerne JA, Domínguez-Kondo N, Milligan J, Štěpán V, Stefanová K, Perrot Y, Villagrasa C, Shin WG, Incerti S, McNamara A, Paganetti H, Perl J, Schuemann J, Faddegon B. Phys Med Biol. 2021 Sep 3;66(17):10.1088/1361-6560/ac1f39. doi: 10.1088/1361-6560/ac1f39. PMID: 34412044 Free PMC article. | 34. | | 35. | | 36. | HEDOS-a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations.Shin J, Xing S, McCullum L, Hammi A, Pursley J, Correa CA, Withrow J, Domal S, Bolch W, Paganetti H, Grassberger C. Phys Med Biol. 2021 Aug 3;66(16):10.1088/1361-6560/ac16ea. doi: 10.1088/1361-6560/ac16ea. PMID: 34293735 Free PMC article. | 37. | | 38. | | 39. | | 40. | | 41. | Intercomparison of Monte Carlo calculated dose enhancement ratios for gold nanoparticles irradiated by X-rays: Assessing the uncertainty and correct methodology for extended beams.Rabus H, Li WB, Villagrasa C, Schuemann J, Hepperle PA, de la Fuente Rosales L, Beuve M, Di Maria S, Klapproth AP, Li CY, Poignant F, Rudek B, Nettelbeck H. Phys Med. 2021 Apr;84:241-253. doi: 10.1016/j.ejmp.2021.03.005. Epub 2021 Mar 23. PMID: 33766478 Free PMC article. | 42. | | 43. | Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy.De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ. J Hepatocell Carcinoma. 2021 Mar 3;8:57-69. doi: 10.2147/JHC.S282062. eCollection 2021. PMID: 33688489 Free PMC article. | 44. | | 45. | Brain-Specific Relative Biological Effectiveness of Protons Based on Long-term Outcome of Patients With Nasopharyngeal Carcinoma.Zhang YY, Huo WL, Goldberg SI, Slater JM, Adams JA, Deng XW, Sun Y, Ma J, Fullerton BC, Paganetti H, Loeffler JS, Lu HM, Chan AW. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):984-992. doi: 10.1016/j.ijrobp.2021.02.018. Epub 2021 Feb 16. PMID: 33600889 Clinical Trial. | 46. | Targeting the DNA replication stress phenotype of KRAS mutant cancer cells.Al Zubaidi T, Gehrisch OHF, Genois MM, Liu Q, Lu S, Kung J, Xie Y, Schuemann J, Lu HM, Hata AN, Zou L, Borgmann K, Willers H. Sci Rep. 2021 Feb 11;11(1):3656. doi: 10.1038/s41598-021-83142-y. PMID: 33574444 Free PMC article. | 47. | Circulating Lymphocyte Counts Early During Radiation Therapy Are Associated With Recurrence in Pediatric Medulloblastoma.Grassberger C, Shinnick D, Yeap BY, Tracy M, G Ellsworth S, Hess CB, Weyman EA, Gallotto SL, Lawell MP, Bajaj B, Ebb DH, Ioakeim-Ioannidou M, Loeffler JS, MacDonald SM, Tarbell NJ, Yock TI. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1044-1052. doi: 10.1016/j.ijrobp.2021.01.035. Epub 2021 Feb 5. PMID: 33556478 Free PMC article. | 48. | | 49. | | 50. | A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.Liu KX, Ioakeim-Ioannidou M, Susko MS, Rao AD, Yeap BY, Snijders AM, Ladra MM, Vogel J, Zaslowe-Dude C, Marcus KJ, Yock TI, Grassberger C, Braunstein SE, Haas-Kogan DA, Terezakis SA, MacDonald SM. Int J Radiat Oncol Biol Phys. 2021 Mar 1;109(3):726-735. doi: 10.1016/j.ijrobp.2020.09.049. Epub 2020 Nov 23. PMID: 33243479 | 51. | Roadmap: proton therapy physics and biology.Paganetti H, Beltran C, Both S, Dong L, Flanz J, Furutani K, Grassberger C, Grosshans DR, Knopf AC, Langendijk JA, Nystrom H, Parodi K, Raaymakers BW, Richter C, Sawakuchi GO, Schippers M, Shaitelman SF, Teo BKK, Unkelbach J, Wohlfahrt P, Lomax T. Phys Med Biol. 2021 Feb 26;66(5):10.1088/1361-6560/abcd16. doi: 10.1088/1361-6560/abcd16. PMID: 33227715 Free PMC article. Review. | 52. | | 53. | | 54. | | 55. | | 56. | | 57. | | 58. | Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, McAvoy S, McAleer MF, Lin SH, Li J, Ghia AJ, Zhu C, Sulman EP, de Groot JF, Heimberger AB, McGovern SL, Grassberger C, Shih H, Ellsworth S, Grosshans DR. Neuro Oncol. 2021 Feb 25;23(2):284-294. doi: 10.1093/neuonc/noaa182. PMID: 32750703 Free PMC article. Clinical Trial. | 59. | | 60. | | 61. | | 62. | | 63. | | 64. | Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists.Ho AY, Wright JL, Blitzblau RC, Mutter RW, Duda DG, Norton L, Bardia A, Spring L, Isakoff SJ, Chen JH, Grassberger C, Bellon JR, Beriwal S, Khan AJ, Speers C, Dunn SA, Thompson A, Santa-Maria CA, Krop IE, Mittendorf E, King TA, Gupta GP. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):227-241. doi: 10.1016/j.ijrobp.2020.05.011. Epub 2020 May 14. PMID: 32417409 Free PMC article. Review. | 65. | Cellular Response to Proton Irradiation: A Simulation Study with TOPAS-nBio.Zhu H, McNamara AL, McMahon SJ, Ramos-Mendez J, Henthorn NT, Faddegon B, Held KD, Perl J, Li J, Paganetti H, Schuemann J. Radiat Res. 2020 Jul 8;194(1):9-21. doi: 10.1667/RR15531.1. PMID: 32401689 Free PMC article. | 66. | | 67. | Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions.Schuemann J, Bagley AF, Berbeco R, Bromma K, Butterworth KT, Byrne HL, Chithrani BD, Cho SH, Cook JR, Favaudon V, Gholami YH, Gargioni E, Hainfeld JF, Hespeels F, Heuskin AC, Ibeh UM, Kuncic Z, Kunjachan S, Lacombe S, Lucas S, Lux F, McMahon S, Nevozhay D, Ngwa W, Payne JD, Penninckx S, Porcel E, Prise KM, Rabus H, Ridwan SM, Rudek B, Sanche L, Singh B, Smilowitz HM, Sokolov KV, Sridhar S, Stanishevskiy Y, Sung W, Tillement O, Virani N, Yantasee W, Krishnan S. Phys Med Biol. 2020 Oct 22;65(21):21RM02. doi: 10.1088/1361-6560/ab9159. PMID: 32380492 Review. | 68. | Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation.Pursley J, El Naqa I, Sanford NN, Noe B, Wo JY, Eyler CE, Hwang M, Brock KK, Yeap BY, Wolfgang JA, Hong TS, Grassberger C. Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):986-995. doi: 10.1016/j.ijrobp.2020.04.027. Epub 2020 Apr 27. PMID: 32353390 Free PMC article. | 69. | | 70. | | 71. | | 72. | Modeling RBE-weighted dose variations in irregularly moving abdominal targets treated with carbon ion beams.Meschini G, Kamp F, Hofmaier J, Reiner M, Sharp G, Paganetti H, Belka C, Wilkens JJ, Carlson DJ, Parodi K, Baroni G, Riboldi M. Med Phys. 2020 Jul;47(7):2768-2778. doi: 10.1002/mp.14135. Epub 2020 Apr 18. PMID: 32162332 | 73. | | 74. | A parameter sensitivity study for simulating DNA damage after proton irradiation using TOPAS-nBio.Zhu H, McNamara AL, Ramos-Mendez J, McMahon SJ, Henthorn NT, Faddegon B, Held KD, Perl J, Li J, Paganetti H, Schuemann J. Phys Med Biol. 2020 Apr 23;65(8):085015. doi: 10.1088/1361-6560/ab7a6b. PMID: 32101803 Free PMC article. | 75. | Intercomparison of dose enhancement ratio and secondary electron spectra for gold nanoparticles irradiated by X-rays calculated using multiple Monte Carlo simulation codes.Li WB, Belchior A, Beuve M, Chen YZ, Di Maria S, Friedland W, Gervais B, Heide B, Hocine N, Ipatov A, Klapproth AP, Li CY, Li JL, Multhoff G, Poignant F, Qiu R, Rabus H, Rudek B, Schuemann J, Stangl S, Testa E, Villagrasa C, Xie WZ, Zhang YB. Phys Med. 2020 Jan;69:147-163. doi: 10.1016/j.ejmp.2019.12.011. Epub 2020 Jan 6. PMID: 31918367 Free PMC article. | 76. | Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy.Bannister AH, Bromma K, Sung W, Monica M, Cicon L, Howard P, Chow RL, Schuemann J, Chithrani DB. Br J Radiol. 2020 Feb 1;93(1106):20190742. doi: 10.1259/bjr.20190742. Epub 2019 Dec 12. PMID: 31778316 Free PMC article. | 77. | | 78. | | 79. | Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol.Bekelman JE, Lu H, Pugh S, Baker K, Berg CD, Berrington de González A, Braunstein LZ, Bosch W, Chauhan C, Ellenberg S, Fang LC, Freedman GM, Hahn EA, Haffty BG, Khan AJ, Jimenez RB, Kesslering C, Ky B, Lee C, Lu HM, Mishra MV, Mullins CD, Mutter RW, Nagda S, Pankuch M, Powell SN, Prior FW, Schupak K, Taghian AG, Wilkinson JB, MacDonald SM, Cahlon O; RadComp (Radiotherapy Comparative Effectiveness Consortium). BMJ Open. 2019 Oct 15;9(10):e025556. doi: 10.1136/bmjopen-2018-025556. PMID: 31619413 Free PMC article. | 80. | | 81. | | 82. | Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.Niyazi M, Niemierko A, Paganetti H, Söhn M, Schapira E, Goldberg S, Adams J, Kim V, Oh KS, Hwang WL, Lu HM, Belka C, Busse PM, Loeffler JS, Shih HA. Radiother Oncol. 2020 Jan;142:154-161. doi: 10.1016/j.radonc.2019.09.008. Epub 2019 Sep 25. PMID: 31563411 | 83. | | 84. | | 85. | Monte Carlo Processing on a Chip (MCoaC)-preliminary experiments toward the realization of optimal-hardware for TOPAS/Geant4 to drive discovery.Abhyankar YS, Dev S, Sarun OS, Saxena A, Joshi R, Darbari H, Sajish C, Sonavane UB, Gavane V, Deshpande A, Dixit T, Harsh R, Badwe R, Rath GK, Laskar S, Faddegon B, Perl J, Paganetti H, Schuemann J, Srivastava A, Obcemea C, Nath AK, Sharma A, Buchsbaum J. Phys Med. 2019 Aug;64:166-173. doi: 10.1016/j.ejmp.2019.06.016. Epub 2019 Jul 16. PMID: 31515016 Free PMC article. | 86. | | 87. | | 88. | | 89. | Validation of a model for physical dose variations in irregularly moving targets treated with carbon ion beams.Meschini G, Seregni M, Molinelli S, Vai A, Phillips J, Sharp GC, Pella A, Valvo F, Ciocca M, Riboldi M, Paganetti H, Baroni G. Med Phys. 2019 Aug;46(8):3663-3673. doi: 10.1002/mp.13662. Epub 2019 Jul 8. PMID: 31206718 | 90. | The microdosimetric extension in TOPAS: development and comparison with published data.Zhu H, Chen Y, Sung W, McNamara AL, Tran LT, Burigo LN, Rosenfeld AB, Li J, Faddegon B, Schuemann J, Paganetti H. Phys Med Biol. 2019 Jul 11;64(14):145004. doi: 10.1088/1361-6560/ab23a3. PMID: 31117056 Free PMC article. | 91. | Patient-Specific Tumor Growth Trajectories Determine Persistent and Resistant Cancer Cell Populations during Treatment with Targeted Therapies.Grassberger C, McClatchy D 3rd, Geng C, Kamran SC, Fintelmann F, Maruvka YE, Piotrowska Z, Willers H, Sequist LV, Hata AN, Paganetti H. Cancer Res. 2019 Jul 15;79(14):3776-3788. doi: 10.1158/0008-5472.CAN-18-3652. Epub 2019 May 21. PMID: 31113818 Free PMC article. | 92. | | 93. | Differential inflammatory response dynamics in normal lung following stereotactic body radiation therapy with protons versus photons.Li Y, Dykstra M, Best TD, Pursley J, Chopra N, Keane FK, Khandekar MJ, Sharp GC, Paganetti H, Willers H, Fintelmann FJ, Grassberger C. Radiother Oncol. 2019 Jul;136:169-175. doi: 10.1016/j.radonc.2019.04.004. Epub 2019 Apr 20. PMID: 31015121 Free PMC article. | 94. | | 95. | Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.Sanford NN, Pursley J, Noe B, Yeap BY, Goyal L, Clark JW, Allen JN, Blaszkowsky LS, Ryan DP, Ferrone CR, Tanabe KK, Qadan M, Crane CH, Koay EJ, Eyler C, DeLaney TF, Zhu AX, Wo JY, Grassberger C, Hong TS. Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):64-72. doi: 10.1016/j.ijrobp.2019.01.076. Epub 2019 Jan 23. PMID: 30684667 | 96. | Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy.Paganetti H, Blakely E, Carabe-Fernandez A, Carlson DJ, Das IJ, Dong L, Grosshans D, Held KD, Mohan R, Moiseenko V, Niemierko A, Stewart RD, Willers H. Med Phys. 2019 Mar;46(3):e53-e78. doi: 10.1002/mp.13390. Epub 2019 Feb 14. PMID: 30661238 Free PMC article. | 97. | | 98. | | 99. | | 100. | | 101. | | 102. | A New Standard DNA Damage (SDD) Data Format.Schuemann J, McNamara AL, Warmenhoven JW, Henthorn NT, Kirkby KJ, Merchant MJ, Ingram S, Paganetti H, Held KD, Ramos-Mendez J, Faddegon B, Perl J, Goodhead DT, Plante I, Rabus H, Nettelbeck H, Friedland W, Kundrát P, Ottolenghi A, Baiocco G, Barbieri S, Dingfelder M, Incerti S, Villagrasa C, Bueno M, Bernal MA, Guatelli S, Sakata D, Brown JMC, Francis Z, Kyriakou I, Lampe N, Ballarini F, Carante MP, Davídková M, Štěpán V, Jia X, Cucinotta FA, Schulte R, Stewart RD, Carlson DJ, Galer S, Kuncic Z, Lacombe S, Milligan J, Cho SH, Sawakuchi G, Inaniwa T, Sato T, Li W, Solov’yov AV, Surdutovich E, Durante M, Prise KM, McMahon SJ. Radiat Res. 2019 Jan;191(1):76-92. doi: 10.1667/RR15209.1. Epub 2018 Nov 8. PMID: 30407901 Free PMC article. | 103. | Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy.Hong TS, Grassberger C, Yeap BY, Jiang W, Wo JY, Goyal L, Clark JW, Crane CH, Koay EJ, Dima S, Eyler CE, Popescu I, DeLaney TF, Zhu AX, Duda DG. NPJ Precis Oncol. 2018 Oct 18;2:22. doi: 10.1038/s41698-018-0065-y. eCollection 2018. PMID: 30374460 Free PMC article. | 104. | | 105. | | 106. | | 107. | Computational Modeling and Clonogenic Assay for Radioenhancement of Gold Nanoparticles Using 3D Live Cell Images.Sung W, Jeong Y, Kim H, Jeong H, Grassberger C, Jung S, Ahn GO, Kim IH, Schuemann J, Lee K, Ye SJ. Radiat Res. 2018 Nov;190(5):558-564. doi: 10.1667/RR15134.1. Epub 2018 Aug 24. PMID: 30142031 Free PMC article. | 108. | | 109. | Geometrical structures for radiation biology research as implemented in the TOPAS-nBio toolkit.McNamara AL, Ramos-Méndez J, Perl J, Held K, Dominguez N, Moreno E, Henthorn NT, Kirkby KJ, Meylan S, Villagrasa C, Incerti S, Faddegon B, Paganetti H, Schuemann J. Phys Med Biol. 2018 Sep 6;63(17):175018. doi: 10.1088/1361-6560/aad8eb. PMID: 30088810 Free PMC article. | 110. | | 111. | | 112. | | 113. | | 114. | Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer.Grassberger C, Hong TS, Hato T, Yeap BY, Wo JY, Tracy M, Bortfeld T, Wolfgang JA, Eyler CE, Goyal L, Clark JW, Crane CH, Koay EJ, Cobbold M, DeLaney TF, Jain RK, Zhu AX, Duda DG. Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1222-1225. doi: 10.1016/j.ijrobp.2018.04.026. Epub 2018 Apr 17. PMID: 29859792 Free PMC article. Clinical Trial. | 115. | | 116. | | 117. | | 118. | | 119. | National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.Haas-Kogan D, Indelicato D, Paganetti H, Esiashvili N, Mahajan A, Yock T, Flampouri S, MacDonald S, Fouladi M, Stephen K, Kalapurakal J, Terezakis S, Kooy H, Grosshans D, Makrigiorgos M, Mishra K, Poussaint TY, Cohen K, Fitzgerald T, Gondi V, Liu A, Michalski J, Mirkovic D, Mohan R, Perkins S, Wong K, Vikram B, Buchsbaum J, Kun L. Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):152-168. doi: 10.1016/j.ijrobp.2018.01.013. PMID: 29619963 Free PMC article. Review. | 120. | Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors.Gentile MS, Yeap BY, Paganetti H, Goebel CP, Gaudet DE, Gallotto SL, Weyman EA, Morgan ML, MacDonald SM, Giantsoudi D, Adams J, Tarbell NJ, Kooy H, Yock TI. Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):719-729. doi: 10.1016/j.ijrobp.2017.11.026. Epub 2017 Nov 23. PMID: 29413284 | 121. | |
|